Kishan Bellamkonda (Former)
1 – 7 of 7
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2023
-
Mark
Combined GLUT1 and OXPHOS inhibition eliminates acute myeloid leukemia cells by restraining their metabolic plasticity
(
- Contribution to journal › Article
- 2019
-
Mark
The WNT5A Agonist Foxy5 Reduces the Number of Colonic Cancer Stem Cells in a Xenograft Mouse Model of Human Colonic Cancer
(
- Contribution to journal › Article
- 2018
-
Mark
Montelukast, a CysLT1 receptor antagonist, reduces colon cancer stemness and tumor burden in a mouse xenograft model of human colon cancer
(
- Contribution to journal › Article
- 2017
-
Mark
Cysteinyl leukotriene receptor 1 facilitates tumorigenesis in a mouse model of colitis-associated colon cancer
(
- Contribution to journal › Article
- 2016
-
Mark
The eicosanoids leukotriene D4 and prostaglandin E2 promote the tumorigenicity of colon cancer-initiating cells in a xenograft mouse model
(
- Contribution to journal › Article
- 2015
-
Mark
The Role of Inflammatory Lipid Mediators on Colon Cancer Initiating Cells (CICs)
(
- Thesis › Doctoral thesis (compilation)
-
Mark
The impact of inflammatory lipid mediators on colon cancer-initiating cells.
(
- Contribution to journal › Article